Recent Finacing
Recent Raise
GliaPharm SA is an EPFL spinoff developing glia-targeted small-molecule therapies using its GliaX discovery platform to restore brain energy metabolism, advancing lead oral candidate GP-119 through regulatory-enabling preclinical studies.
